Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Targeted Drug HER2 Inhibitors for NSCLC market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Targeted Drug HER2 Inhibitors for NSCLCmarket, defines the market attractiveness level of Targeted Drug HER2 Inhibitors for NSCLC market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Targeted Drug HER2 Inhibitors for NSCLC industry, describes the types of Targeted Drug HER2 Inhibitors for NSCLC market, the applications of major players and the market size, and deeply analyzes the current situation of the global Targeted Drug HER2 Inhibitors for NSCLC market and the development prospects and opportunities of Targeted Drug HER2 Inhibitors for NSCLC industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Targeted Drug HER2 Inhibitors for NSCLC market in Chapter 13.
By Player:
Boehringer-Ingelheim
Mylan
Roche
Biocon
By Type:
Afatinib
Trastuzumab
Other
By End-User:
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Targeted Drug HER2 Inhibitors for NSCLC Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Targeted Drug HER2 Inhibitors for NSCLC Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Targeted Drug HER2 Inhibitors for NSCLC Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Targeted Drug HER2 Inhibitors for NSCLC Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Targeted Drug HER2 Inhibitors for NSCLC Market Analysis and Outlook to 2022
-
7.1 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.2 United States Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.4 China Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.5 Japan Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.6 India Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
-
7.7 South Korea Targeted Drug HER2 Inhibitors for NSCLC Consumption (2017-2022)
8 Region and Country-wise Targeted Drug HER2 Inhibitors for NSCLC Market Analysis and Outlook to 2028
-
8.1 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.2 United States Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.4 China Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.5 Japan Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.6 India Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
-
8.7 South Korea Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast (2022-2028)
9 Global Targeted Drug HER2 Inhibitors for NSCLC Market Outlook by Types and Applications to 2022
-
9.1 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Afatinib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adenocarcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Large Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
10 Global Targeted Drug HER2 Inhibitors for NSCLC Market Outlook by Types and Applications to 2028
-
10.1 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Squamous Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adenocarcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Large Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
11 Global Targeted Drug HER2 Inhibitors for NSCLC Import and Export Analysis (Top 5 Countries)
-
11.1 Global Targeted Drug HER2 Inhibitors for NSCLC Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Targeted Drug HER2 Inhibitors for NSCLC Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Targeted Drug HER2 Inhibitors for NSCLC Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Targeted Drug HER2 Inhibitors for NSCLC Market Competitive Analysis
-
14.1 Boehringer-Ingelheim
-
14.1.1 Boehringer-Ingelheim Company Details
-
14.1.2 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
14.2 Mylan
-
14.2.1 Mylan Company Details
-
14.2.2 Mylan Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
14.4 Biocon
-
14.4.1 Biocon Company Details
-
14.4.2 Biocon Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Targeted Drug HER2 Inhibitors for NSCLC
-
Figure Targeted Drug HER2 Inhibitors for NSCLC Picture
-
Table Global Targeted Drug HER2 Inhibitors for NSCLC Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Drug HER2 Inhibitors for NSCLC Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Targeted Drug HER2 Inhibitors for NSCLC Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Targeted Drug HER2 Inhibitors for NSCLC Consumption by Country (2017-2022)
-
Figure United States Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Table Europe Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Figure China Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Japan Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Figure India Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Figure South Korea Targeted Drug HER2 Inhibitors for NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast by Country (2022-2028)
-
Figure United States Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Targeted Drug HER2 Inhibitors for NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Afatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Squamous Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Adenocarcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Large Cell Carcinoma of NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Afatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Squamous Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenocarcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large Cell Carcinoma of NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Targeted Drug HER2 Inhibitors for NSCLC Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Targeted Drug HER2 Inhibitors for NSCLC Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer-Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Targeted Drug HER2 Inhibitors for NSCLC Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Targeted Drug HER2 Inhibitors for NSCLC Product and Service
-
